Abstract:Introduction: This retrospective study aimed to determine the percentage of MRI-detected breast cancers diagnosed using targeted ultrasound and standard 14-gauge (14g) biopsy in the setting of an Australian breast MRI service. This is of clinical relevance because malignancies not identifiable on mammography or by ultrasound may then require more invasive, technically demanding and costly MRI-guided interventional procedures, usually by large-core vacuum-assisted biopsy (VAB) or hook-wire localisation with open surgical biopsy. Methods: On review of the 12-year period 2006-2018, we identified 67 new breast cancer events in 64 women where the diagnosis was made on the basis of the MRI scan findings either alone (n = 60) or in combination with a concurrent mammogram (n = 7), with no recorded clinical abnormality. The percentage in which malignancy was confirmed on histopathology using targeted ultrasound in combination with 14g biopsy was determined versus other biopsy methods, for both invasive cancer and in situ disease. Results: Ultrasound-guided 14g biopsy was successful in establishing the presence of malignancy in 42/46 (91%) of events with a final diagnosis of invasive cancer, with 2 more proven by MRI-guided interventional procedures (1 VAB and 1 hook-wire) and 1 by open surgical biopsy. In the final case, a 5 mm focus on MRI with no sonographic correlate at the initial presentation was only identified and biopsied by ultrasound at 12-month follow-up. For events with a final diagnosis of DCIS/pLCIS (pleomorphic LCIS, n = 2), US-guided 14g biopsy was successful in 10/21 (48%), while 4/7 events with corresponding mammographic microcalcifications were proven by x-ray stereotactic interventions. A further 5 events had MRI-guided interventions (3 VAB and 2 hook-wires) and 1 an open surgical biopsy to confirm malignancy. In the final case (a woman with a 30 × 20 mm focal area of non-mass enhancement with corresponding microcalcifications consistent with DCIS), a pathologic diagnosis was not made until the patient presented 5 years later with invasive disease. There were also 3 instances of upgrades to invasion on final surgical pathology, one from pLCIS to microinvasion and 2 others from DCIS to IDC. Among the DCIS/pLCIS events, semi-random 14g core biopsy (sampling at the expected location of the MRI abnormality without a specific sonographic correlate) proved to be successful in 3 women. Conclusion: Ultrasound-guided 14g core biopsy established a malignant diagnosis in 91% of invasive cancers and in 48% of DCIS/pLCIS cases. This relatively non-invasive, technically easy to perform and low-cost biopsy procedure can be used immediately when targeted ultrasound shows a correlate for a suspicious MRI scan finding. Careful imaging-pathologic correlation is required after 14g biopsy, and a discordant result will usually prompt recourse to an MRI-guided VAB or hook-wire localisation.

Application of MRI-guided vacuum-assisted breast biopsy: Initial clinical experience

Mammotome® Biopsy System for the Resection of Breast Lesions: Clinical Experience in Two High-Volume Teaching Hospitals

The value of transrectal ultrasound-guided systematic prostate biopsy and additional targeted cores from suspicious magnetic resonance imaging in the biopsy of prostate cancer

The Value of Automated Breast Volume Scanning, Combined with Virtual Touch Tissue Imaging Quantification in the Differential Diagnosis of Benign and Malignant Breast Lesion

The clinical application of high-resolution ultrasound-guided mammotome minimally invasive biopsy system in resection of breast lesions

Application value of MRI-guided wire localization to the non-palpable breast lesions only shown in Breast MRI

Prospective Evaluation of Ultrasound in a Novel Position with MRI Virtual Navigation for MRI-Detected Only Breast Lesions: A Pilot Study of a More Efficient and Economical Method

Vacuum-assisted biopsy system for breast lesions: a potential therapeutic approach

[Value of Magnetic Resonance Imaging in Diagnosing Breast Lesions Which Need Biopsy].

Real-time precision targeted prostate biopsy using transrectal ultrasound-magnetic resonance fusion

MRI-guided Breast Lesion Localization and Lesion Analysis

MRI-guided core needle biopsy of the breast: Radiology-pathology correlation and impact on clinical management

Ultrasound-guided minimally invasive biopsy in the diagnosis of minor breast lesions: the contrast between core needle biopsy and vacuum-assisted biopsy

Percutaneous removal of benign breast masses using minimally invasive method with real-time three-dimensional ultrasound guidance

Clinical research of automated breast volume scanner and MRI in diagnosis of breast cancer

Clinical Application of Ultrasound-Guided Needle Biopsy in Mammary Disease

The value of MRI for downgrading of breast suspicious lesions detected on ultrasound

Real-time Image Guided Brain Biopsy Using Low-Field Intraoperative Magnetic Resonance Imaging: Preliminary Clinical Report

12-year review of MRI-detected breast cancers. How often was a diagnosis of malignancy established using targeted ultrasound and standard 14-gauge core biopsy?

Localization of breast lesions using magnetic resonance imaging/ultrasound image fusion virtual navigation technology: a preliminary study

Evaluation of the Role of Dynamic Contrast-Enhanced Mr Imaging for Patients with Bi-Rads 3-4 Microcalcifications